SCHEMBL240362

SCHEMBL240362

c1ccc(N(c2ccccc2)c2ccc3c(c2)C2(c4ccccc4-3)c3ccccc3-c3ccc(N(c4ccccc4)c4ccccc4)cc32)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 14/20 0.44
KDM4E B2RXH2 2/20 0.41
MAPT P10636 2/20 0.41
ALDH1A1 P00352 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
LMNA P02545 1/20 0.36
OPRK1 P41145 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CRHBP P24387 1/20 0.35
ATM Q13315 1/20 0.35
CRHR2 Q13324 1/20 0.35
TLR9 Q9NR96 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29373692 1.00 PDK2 (0.44) PDK2KDM4EMAPTALDH1A1L3MBTL1
SCHEMBL11966151 1.00 PDK2 (0.44) PDK2KDM4EMAPTALDH1A1L3MBTL1
SCHEMBL29352888 1.00 PDK2 (0.44) PDK2KDM4EMAPTALDH1A1L3MBTL1
SCHEMBL29947665 1.00 PDK2 (0.44) PDK2KDM4EMAPTALDH1A1L3MBTL1
SCHEMBL11974121 1.00 PDK2 (0.44) PDK2KDM4EMAPTALDH1A1L3MBTL1
SCHEMBL23544434 1.00 PDK2 (0.44) PDK2KDM4EMAPTALDH1A1L3MBTL1
SCHEMBL12559952 1.00 PDK2 (0.44) PDK2KDM4EMAPTALDH1A1L3MBTL1
SCHEMBL15183519 1.00 PDK2 (0.44) PDK2KDM4EMAPTALDH1A1L3MBTL1
SCHEMBL15183504 1.00 PDK2 (0.44) PDK2KDM4EMAPTALDH1A1L3MBTL1
SCHEMBL29373279 1.00 PDK2 (0.44) PDK2KDM4EMAPTALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 541 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260082802-A1 ORGANIC ELECTRONIC COMPONENT AND METHOD FOR PRODUCING AN ORGANIC ELECTRONIC COMPONENT PICTIVA DISPLAYS INTERNATIONAL LIMITED (IE) 2026-03-19 US claimed
US-11849598-B2 Organic light-emitting component having a light-emitting layer as part of a charge generation layer PICTIVA DISPLAYS INTERNATIONAL LIMITED (IE) 2023-12-19 US claimed
US-20220085338-A1 ORGANIC LIGHT-EMITTING COMPONENT HAVING A LIGHT-EMITTING LAYER AS PART OF A CHARGE GENERATION LAYER PICTIVA DISPLAYS INTERNATIONAL LIMITED (IE) 2022-03-17 US claimed
US-11211590-B2 Organic light-emitting component having a light-emitting layer as part of a charge generation layer PICTIVA DISPLAYS INTERNATIONAL LIMITED (IE) 2021-12-28 US claimed
US-11056660-B2 Organic optoelectronic component and method for producing the same PICTIVA DISPLAYS INTERNATIONAL LIMITED (IE) 2021-07-06 US claimed
US-20200185656-A1 Organic Light-Emitting Component Having a Light-Emitting Layer as Part of a Charge Generation Layer OSRAM OLED GMBH (DE) 2020-06-11 US claimed
US-10483466-B2 P-doping cross-linking of organic hole transporters SIEMENS AKTIENGESELLSCHAFT (DE) 2019-11-19 US claimed
US-20180205028-A1 ORGANIC OPTOELECTRONIC COMPONENT AND METHOD FOR PRODUCING THE SAME DOLYA HOLDCO 5 LIMITED (IE) 2018-07-19 US claimed
EP-2478576-B9 ORGANIC ELECTRONIC DEVICE AND DOPANT FOR DOPING AN ORGANIC SEMICONDUCTING MATRIX MATERIAL OSRAM OLED GMBH (DE) 2017-09-06 EP claimed
EP-2478576-B1 ORGANIC ELECTRONIC DEVICE AND DOPANT FOR DOPING AN ORGANIC SEMICONDUCTING MATRIX MATERIAL OSRAM OLED GMBH (DE) 2017-05-31 EP claimed
EP-2443680-B1 METHOD OF MANUFACTURING A HOLE TRANSPORT LAYER WITH P-DOPING SIEMENS AG (DE) 2016-08-10 EP claimed
US-20150097167-A1 ORGANIC LIGHT EMITTING DEVICE AND ORGANIC LIGHT EMITTING DISPLAY HAVING THE SAME LG DISPLAY CO., LTD. (KR) 2015-04-09 US claimed
US-8610113-B2 Material for a hole transport layer with p-dopant SIEMENS AKTIENGESELLSCHAFT (DE) 2013-12-17 US claimed
US-20120146006-A1 MATERIAL FOR A HOLE TRANSPORT LAYER WITH P-DOPANT NOVALED GMBH (DE) 2012-06-14 US claimed
US-20120003485-A1 Monolayers of organic compounds on metal oxide surfaces or metal surfaces containing oxide and component produced therewith based on organic electronics SIEMENS AKTIENGESELLSCHAFT (DE) 2012-01-05 US claimed
US-20070262704-A1 Carbazole-based Compounds and Their Application Wong, Ken-Tsung (TW) 2007-11-15 US claimed
US-12622166-B2 Organic electronic device comprising an anode layer, a cathode layer, at least one emission layer (EML) and at least one hole injection layer (HIL) NOVALED GMBH (DE) 2026-05-05 US disclosed
US-20260082802-A1 ORGANIC ELECTRONIC COMPONENT AND METHOD FOR PRODUCING AN ORGANIC ELECTRONIC COMPONENT PICTIVA DISPLAYS INTERNATIONAL LIMITED (IE) 2026-03-19 US disclosed
US-20070262703-A1 2,2'-Disubstituted 9,9'-Spirobifluorene-based Triaryldiamines and Their Application Wong, Ken-Tsung (TW) 2007-11-15 US disclosed
US-20070262703-A1 2,2'-Disubstituted 9,9'-Spirobifluorene-based Triaryldiamines and Their Application Wong, Ken-Tsung (TW) 2007-11-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070262704-A1 Carbazole-based Compounds and Their Application CCNI, CYP3A5, CCNC PDK2 876/4885KDM4E 1107/4885MAPT 4235/4885
US-20260082802-A1 ORGANIC ELECTRONIC COMPONENT AND METHOD FOR PRODUCING AN ORGANIC ELECTRONIC COMPONENT FLNA, FLNB, CDH1 PDK2 2505/4885KDM4E 1010/4885MAPT 526/4885
US-12622166-B2 Organic electronic device comprising an anode layer, a cathode layer, at least one emission layer (EML) and at least one hole injection layer (HIL) EMC2, EMC1, EMC3 PDK2 2885/4885KDM4E 1839/4885MAPT 2846/4885
US-20070262703-A1 2,2'-Disubstituted 9,9'-Spirobifluorene-based Triaryldiamines and Their Application SLC9B2, SLC9A2, SLC29A2 PDK2 205/4885KDM4E 3842/4885MAPT 4093/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.